Immune response to SARS-CoV-2 after a booster of mRNA-1273: an open-label phase 2 trial. Chu L, Vrbicky K, Montefiori D, Huang W, et al. Nat Med 2022;28:1042-1049.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chu L, Vrbicky K, Montefiori D, Huang W, et al. Immune response to SARS-CoV-2 after a booster of mRNA-1273: an open-label phase 2 trial. Nat Med 2022;28:1042-1049.
PMID: 35241844